In this video, Matthew C. Tattersall, DO, MS, discusses persistent asthma and its association with carotid plaque burden, which is a strong predictor of atherosclerotic cardiovascular disease events, in the...
In this video, Shaan Khurshid, MD, MPH, talks about his team's study that analyzed a database of nearly 90,000 people and found that concentrated physical activity (1-2 days per week) offers similar heart...
In this article, Michael J Bloch, MD, discusses the usage of RAS-blocking agents, slowing the progression of end-stage renal disease, and reducing cardiovascular events in patients with advanced kidney...
In this article, Michael Bloch, MD, and Evan Bloch discuss findings from the SELECT trial, including the use of the glucagon-like peptide 1 receptor agonist, semaglutide, to reduce the risk of major...
In this video, Paul M. Ridker, MD, MPH, discusses his team's recent study, which found that vascular inflammation levels in patients on statin therapy are better predictors of future cardiovascular events...
Early adulthood hypertension or increased blood pressure is associated with negative brain changes later in life including lower regional brain volumes and worse white matter integrity, factors that are...
In this episode, Seth Martin, MD, speaks with Francoise Marvel, MD, about innovative approaches to implementing prevention guidelines, including the future of digital health and cardiovascular care.
In this commentary, Michael J. Bloch, MD, writes about the epidemiological link between influenza infection and cardiovascular events and the potential benefits of influenza vaccination on cardiovascular...
In this commentary, Michael J. Bloch, MD writes about controversies in the effect of dietary cholesterol and egg consumption on cardiovascular events and mortality.
In this article, James Matera, DO, writes about a newer agent, finarenone, which is a nonsteroidal, selective mineralocorticoid receptor antagonist that can treat chronic kidney disease.
